"Therapeutic Equivalency" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.
| Descriptor ID |
D013810
|
| MeSH Number(s) |
G03.787.559 G07.690.725.898
|
| Concept/Terms |
Therapeutic Equivalency- Therapeutic Equivalency
- Clinical Equivalencies
- Equivalencies, Clinical
- Equivalency, Clinical
- Generic Equivalency
- Equivalencies, Generic
- Equivalency, Generic
- Generic Equivalencies
- Equivalencies, Therapeutic
- Therapeutic Equivalencies
- Equivalency, Therapeutic
- Bioequivalence
- Bioequivalences
- Clinical Equivalency
|
Below are MeSH descriptors whose meaning is more general than "Therapeutic Equivalency".
Below are MeSH descriptors whose meaning is more specific than "Therapeutic Equivalency".
This graph shows the total number of publications written about "Therapeutic Equivalency" by people in this website by year, and whether "Therapeutic Equivalency" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Therapeutic Equivalency" by people in Profiles.
-
Chai PR, Pereira LM, Jambaulikar GD, Carrico AW, O'Cleirigh C, Mayer KH, Boyer EW. Short Communication: Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills. AIDS Res Hum Retroviruses. 2019 04; 35(4):361-363.
-
Treadwell JR, Uhl S, Tipton K, Shamliyan T, Viswanathan M, Berkman ND, Sun X, Coleman CI, Elshaug AG, Singh S, Wang SY, Ramakrishnan R. Assessing equivalence and noninferiority. J Clin Epidemiol. 2012 Nov; 65(11):1144-9.
-
Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010 Mar 26; 70(5):605-21.
-
Lehmann DF, Guharoy R, Page N, Hirschman K, Ploutz-Snyder R, Medicis J. Formulary management as a tool to improve medication use and gain physician support. Am J Health Syst Pharm. 2007 Mar 01; 64(5):464-6.
-
Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med. 2005 Oct 06; 353(14):1516-22.
-
Nusbaum NJ. Making "me-too" drugs benefit the public. Am J Med Qual. 2002 Nov-Dec; 17(6):215-7.
-
Schachtner JM, Guharoy R, Medicis JJ, Newman N, Speizer R. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Health Syst Pharm. 2002 Mar 15; 59(6):529-33.